Expert overview on the recent developments in mantle cell lymphoma

Round-up of the latest research on lung cancer

Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer

Screening to identify unsuitable candidates for ipilimumab in advanced melanoma

Nivolumab alone superior to ipilimumab alone in advanced melanoma

Extended adjuvant therapy for HER2-positive early breast cancer

Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma

ASCO 2015: Latest developments in multiple myeloma

Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer

ASCO 2015: Latest in chronic lymphocytic leukaemia

Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma

Subgroup analysis of molecular markers in phase III study of high risk low-grade glioma